Thats what I said on the 2020 site. BTT has lost so many good posters because of there constant pushing of hair transplants and extreme moderation. Its just too much effort to post there now because of that F-head Winston. And that other c*** knocker Payday has his head that far up Spencers ***.And isn't it interesting how now, right after Hellouser conducted interviews at the Congress, BTT conducts interviews with Replicel and Histogen right afterwards?? What a coincidence!!! Hahaha
Thats what I said on the 2020 site. BTT has lost so many good posters because of there constant pushing of hair transplants and extreme moderation. Its just too much effort to post there now because of that F-head Winston. And that other c*** knocker Payday has his head that far up Spencers ***.
To determine the effect of GPR44 antagonist or COX inhibitor such as TM30089, indomethacin andrefoxcib, they were applied to DHT-treated DPCs. According to real time-PCR and Western blot assay, androgenreceptor (AR), PGD2 synthase and GPR44/CRTh2 was upregulated in 1-100nM DHT treated samples. The GPR44antagonist or COX inhibitor inhibited the level of AR, type 2 5α-reductase (5αR2), and PGD2 synthase. Theseeffects positively act on DPCs viability
This congress was only waste of time. Nothing new, nothing special to be excited. Just like always. Guys, don’t expect nothing new till 2030.
Chill with the negativity. In just 1-3 years we can see a replacement of finasteride + minoxidil with Seti + SM. That's what I'm hoping for.
I believe the problem is not in the follicle itself as miniaturized follicles when transplanted in mice regrew to their original size (2002 study). If the problem was the follicle that would not happen and they would remain small after implanted. Therefore, the problem can only be in the scalp, the environment of the follicle. So, there is something in the balding region of the head that is preventing its hair follicles from growing normally, that's what needs to be figured out. Once we know what it is, baldness will be reversible. The good news, well it's not news (2002) is the balding follicles are not diseased, or weak, or unhealthy, or dying, they are only being kept from growing for some reason.
The 2002 study you refer too, is very important in terms of trying to understand what is really going on in hair follicle miniaturisation. What is just as important as the male pattern baldness follicles enlarging by around 400%, is what happened to the so called androgen neutral large follicles from the same men. These reduced in size by around 40%, resulting in all the various follicles used ending up the same size within very close limits.
What is clear from this, is that external conditions are adjusting all the follicles to one particular size. There is only one recognised growth control that could explain this, and i discuss this study in my article.
https://independent.academia.edu/StephenFoote/Papers
I have to say i don't see any differences in the research directions of this conference, to those of twenty years ago. The WNT's pathway is a big no no, and anything based on this that does work will never be licensed. Fuchs demonstrated many years ago that testing this in mice produced much increased hair growth, and tumours.
People on the forums ask why is it so hard to make any real progress in understanding hair follicle miniaturisation? Well very simply follicle growth restriction research, completely ignores the very basic widely accepted tissue growth controls. For some reason traditional hair follicle research seems to think that two things can occupy the same space at the same time? Basic physics says otherwise.